Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gemini Therapeutics Inc (NQ: GMTX ) N/A UNCHANGED Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gemini Therapeutics Inc < Previous 1 2 3 Next > Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation February 21, 2023 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket December 28, 2022 Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. Via Benzinga 7 Short-Squeeze Stocks for Bold Contrarians to Consider November 21, 2022 While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists. Via InvestorPlace Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company August 10, 2022 Via Benzinga GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX August 12, 2022 From Kahn Swick & Foti, LLC Via Business Wire GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders August 10, 2022 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session August 10, 2022 Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday August 11, 2022 Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. Via Benzinga Gemini Therapeutics and Disc Medicine Announce Merger Agreement August 10, 2022 From Gemini Therapeutics, Inc. Via Business Wire The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More April 14, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 10 Biggest Price Target Changes For Friday March 11, 2022 Needham cut the price target on OppFi Inc. (NYSE: OPFI) from $10 to $4.5. OppFi shares rose 5.3% to $3.20 in pre-market trading. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022 March 11, 2022 Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra... Via Benzinga What 5 Analyst Ratings Have To Say About Gemini Therapeutics March 03, 2022 Within the last quarter, Gemini Therapeutics (NASDAQ:GMTX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 March 03, 2022 Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... Via Benzinga 10 Biggest Price Target Changes For Thursday March 03, 2022 Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading. Via Benzinga Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold March 01, 2022 Jefferies has cut Gemini Therapeutics Inc (NASDAQ: GMTX) to Hold as the Company explores alternatives. The analyst Chris Howerton has also reduced the price target... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 01, 2022 During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 March 01, 2022 Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... Via Benzinga 10 Biggest Price Target Changes For Tuesday March 01, 2022 Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading. Via Benzinga Gemini Therapeutics Provides Corporate Update February 28, 2022 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics Provides GEM103 Program Update January 10, 2022 From Gemini Therapeutics, Inc. Via Business Wire 46 Biggest Movers From Yesterday December 16, 2021 Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... Via Benzinga Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update December 15, 2021 Toward the end of trading Wednesday, the Dow traded up 0.35% to 35,669.27 while the NASDAQ rose 0.44% to 15,304.76. The S&P also rose, gaining 0.51% to 4,657.83. The U.S. has... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 15, 2021 Gainers Biofrontera (NASDAQ: Via Benzinga Gemini Therapeutics Shares Jump As HC Wainwright Sees Over 500% Upside December 15, 2021 H.C. Wainwright initiated coverage of Gemini Therapeutics Inc (NASDAQ: GMTX) with a Buy rating and $20 price target. In the near term, the expected... Via Benzinga Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb December 15, 2021 Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has... Via Benzinga 36 Stocks Moving In Wednesday's Mid-Day Session December 15, 2021 Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 December 15, 2021 Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 15, 2021 Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.